Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersOperating IncomePreferred Dividend PaymentsProfit After TaxRevenueShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

cbdMD (YCBD) EBIT (2016 - 2025)

cbdMD's EBIT history spans 10 years, with the latest figure at -$286288.0 for Q4 2025.

  • For Q4 2025, EBIT fell 231.84% year-over-year to -$286288.0; the TTM value through Dec 2025 reached -$2.4 million, down 1.15%, while the annual FY2025 figure was -$2.2 million, 34.77% up from the prior year.
  • EBIT for Q4 2025 was -$286288.0 at cbdMD, up from -$685816.0 in the prior quarter.
  • Across five years, EBIT topped out at -$86272.0 in Q4 2024 and bottomed at -$33.1 million in Q2 2022.
  • The 5-year median for EBIT is -$1.7 million (2023), against an average of -$6.2 million.
  • The largest annual shift saw EBIT plummeted 1328.74% in 2021 before it soared 97.92% in 2024.
  • A 5-year view of EBIT shows it stood at -$25.1 million in 2021, then skyrocketed by 83.91% to -$4.0 million in 2022, then soared by 73.66% to -$1.1 million in 2023, then skyrocketed by 91.91% to -$86272.0 in 2024, then crashed by 231.84% to -$286288.0 in 2025.
  • Per Business Quant, the three most recent readings for YCBD's EBIT are -$286288.0 (Q4 2025), -$685816.0 (Q3 2025), and -$904686.0 (Q2 2025).